148 related articles for article (PubMed ID: 17971509)
1. Oxyntomodulin ameliorates glucose intolerance in mice fed a high-fat diet.
Parlevliet ET; Heijboer AC; Schröder-van der Elst JP; Havekes LM; Romijn JA; Pijl H; Corssmit EP
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E142-7. PubMed ID: 17971509
[TBL] [Abstract][Full Text] [Related]
2. CNTO736, a novel glucagon-like peptide-1 receptor agonist, ameliorates insulin resistance and inhibits very low-density lipoprotein production in high-fat-fed mice.
Parlevliet ET; Schröder-van der Elst JP; Corssmit EP; Picha K; O'Neil K; Stojanovic-Susulic V; Ort T; Havekes LM; Romijn JA; Pijl H
J Pharmacol Exp Ther; 2009 Jan; 328(1):240-8. PubMed ID: 18849357
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of oxyntomodulin and GLP-1 on glucose metabolism.
Du X; Kosinski JR; Lao J; Shen X; Petrov A; Chicchi GG; Eiermann GJ; Pocai A
Am J Physiol Endocrinol Metab; 2012 Jul; 303(2):E265-71. PubMed ID: 22621866
[TBL] [Abstract][Full Text] [Related]
4. [Effect of free fatty acid-induced insulin resistance on plasma ghrelin level: an experimental study with rats].
Li L; Yang GY
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1645-8. PubMed ID: 15569462
[TBL] [Abstract][Full Text] [Related]
5. Temporal and dietary fat content-dependent islet adaptation to high-fat feeding-induced glucose intolerance in mice.
Winzell MS; Magnusson C; Ahrén B
Metabolism; 2007 Jan; 56(1):122-8. PubMed ID: 17161234
[TBL] [Abstract][Full Text] [Related]
6. GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet.
Parlevliet ET; de Leeuw van Weenen JE; Romijn JA; Pijl H
Am J Physiol Endocrinol Metab; 2010 Aug; 299(2):E318-24. PubMed ID: 20530733
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the glucose tolerance test in mice.
Andrikopoulos S; Blair AR; Deluca N; Fam BC; Proietto J
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1323-32. PubMed ID: 18812462
[TBL] [Abstract][Full Text] [Related]
8. A1 adenosine receptor partial agonist lowers plasma FFA and improves insulin resistance induced by high-fat diet in rodents.
Dhalla AK; Wong MY; Voshol PJ; Belardinelli L; Reaven GM
Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1358-63. PubMed ID: 17227958
[TBL] [Abstract][Full Text] [Related]
9. Four weeks high fat feeding induces insulin resistance without affecting dopamine release or gene expression patterns in the hypothalamus of C57Bl6 mice.
de Leeuw van Weenen JE; Hu L; Jansen-Van Zelm K; de Vries MG; Tamsma JT; Romijn JA; Pijl H
Brain Res; 2009 Jan; 1250():141-8. PubMed ID: 19028458
[TBL] [Abstract][Full Text] [Related]
10. Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice.
van den Hoek AM; Heijboer AC; Voshol PJ; Havekes LM; Romijn JA; Corssmit EP; Pijl H
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E238-45. PubMed ID: 16940471
[TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice.
Ayala JE; Bracy DP; Julien BM; Rottman JN; Fueger PT; Wasserman DH
Diabetes; 2007 Apr; 56(4):1025-33. PubMed ID: 17229936
[TBL] [Abstract][Full Text] [Related]
12. Leptin deficiency per se dictates body composition and insulin action in ob/ob mice.
van den Hoek AM; Teusink B; Voshol PJ; Havekes LM; Romijn JA; Pijl H
J Neuroendocrinol; 2008 Jan; 20(1):120-7. PubMed ID: 18081560
[TBL] [Abstract][Full Text] [Related]
13. [Effects of visfatin gene overexpression on insulin sensitivity in the insulin-resistant rats induced by high-fat diet].
Qin S; Li L; Yang GY; Li RZ; Li K; Qi XY; Li SB; Chen WW; Liu H; Tang Y; Boden G
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):365-8. PubMed ID: 18581886
[TBL] [Abstract][Full Text] [Related]
14. Oxyntomodulin increases the concentrations of insulin and glucose in plasma but does not affect ghrelin secretion in Holstein cattle under normal physiological conditions.
ThanThan S; Zhao H; Yannaing S; Ishikawa T; Kuwayama H
Domest Anim Endocrinol; 2010 Oct; 39(3):163-70. PubMed ID: 20705414
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet.
Weisinger RS; Stanley TK; Begg DP; Weisinger HS; Spark KJ; Jois M
Physiol Behav; 2009 Aug; 98(1-2):192-7. PubMed ID: 19465040
[TBL] [Abstract][Full Text] [Related]
16. Reducing plasma free fatty acids by acipimox improves glucose tolerance in high-fat fed mice.
Ahrén B
Acta Physiol Scand; 2001 Feb; 171(2):161-7. PubMed ID: 11350276
[TBL] [Abstract][Full Text] [Related]
17. Oxyntomodulin attenuates exendin-4-induced hypoglycemia in cattle.
ThanThan S; Asada Y; Saito T; Ochiiwa K; Zhao H; Yannaing S; Kuwayama H
Domest Anim Endocrinol; 2013 Feb; 44(2):70-80. PubMed ID: 23122871
[TBL] [Abstract][Full Text] [Related]
18. Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet.
Jang SM; Yee ST; Choi J; Choi MS; Do GM; Jeon SM; Yeo J; Kim MJ; Seo KI; Lee MK
Int Immunopharmacol; 2009 Jan; 9(1):113-9. PubMed ID: 19013541
[TBL] [Abstract][Full Text] [Related]
19. Fish oil and argan oil intake differently modulate insulin resistance and glucose intolerance in a rat model of dietary-induced obesity.
Samane S; Christon R; Dombrowski L; Turcotte S; Charrouf Z; Lavigne C; Levy E; Bachelard H; Amarouch H; Marette A; Haddad PS
Metabolism; 2009 Jul; 58(7):909-19. PubMed ID: 19394055
[TBL] [Abstract][Full Text] [Related]
20. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.
Zinker B; Mika A; Nguyen P; Wilcox D; Ohman L; von Geldern TW; Opgenorth T; Jacobson P
Metabolism; 2007 Mar; 56(3):380-7. PubMed ID: 17292727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
